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Background: The early repolarisation (ER) pattern has been asso-
ciated with sudden cardiac death. The prevalence of this has not
been described in the Indian population. Its prevalence varies in
various ethnic groups.
Methods: The aim of this study was to look at the incidence of ER
in healthy young Indian population and compare it with other
ethnic origins.
ECGs were obtained from 554 apparently healthy Indian in-
dividuals attending cardiac screening. Participants completed a
questionnaire stating symptoms, medical and family history, and
physical activity (42% 10 hr. /wk.). Individuals were aged from 12
to 35. Heart rate, QRS duration, QTc interval and voltage criteria
for LVH was reported. The presence of ER was reported indepen-
dently by three cardiologists (RN, GM, NK), with decisions by
consensus. If required, a senior colleague (EB) adjudicated. ER was
defined as J-point elevation of 0.1mV in two consecutive inferior
or lateral leads and classified as notched or slurred. ST segments
were defined as rapidly ascending or horizontal/descending.
Results: ER was seen in 52 individuals, 48% in lateral, 42% in
inferior and 21% in infero-lateral leads. J waves were notched in
56% and slurred in 62%. 90% of ER was associated with a rapidly
ascending ST segment. The higher mean age was also seen in
lateral (20.8±5.8 vs 18.1±4.8), inferior (22.2±6.8 vs 18.6±5.2),
notched (22.6±8.0 vs 18.5±5.2) and up-sloping ST segment
(21.4±6.8 vs 17.9±4.7) groups. 18-35yr olds exercised more than
under 18s (62.0% vs 31.2% 10 hours/week). ER was associated
with lower heart rate and shorter QTc. ER was more common in
males and the one who were physically active.
Conclusion: ER is present in 9.4% of healthy young Indians. This is
comparable to population studies although lower than in African
Americans and athletic white Caucasians. The study population
was young and active and prevalence was expected to be higher.
Our study shows individuals with ER were older in contrast to
previous studies that have associated ER with younger age. This
may reflect the youth of our population, endocrine influences at
puberty and higher exercise levels in 18-35yr olds. There may
therefore be a peak prevalence of ER in the late teenage years or
early 20s. Larger studies are required.
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Background: Identification of cardiovascular risk factors at the
earliest stage of life is vital particularly in the infants with intra-
uterine growth restriction. We determined the difference in cord
blood lipid profile and insulin level between small-for-gestational-
age (SGA) newborns and appropriate-for-gestational-age (AGA)
full-term newborns.
Methods: In this cross-sectional study, full-term infants whowere
born between June 20, 2013 and August 19, 2013 at the obstetric
unit of Gandhi Medical College and Hospital, Secunderabad, India
were enrolled in the study. Based on the gestational age and body
weight, these newborns were divided in to SGA group (n¼51; test
group) and AGA group (n¼52; control group) after receiving the
informed consent from all participant’s mothers. Differences in
cord blood lipid profile and insulin levels were estimated between
the two groups.
Results: The newborns in the SGA group had higher cholesterol
levels (60.21±15.42 vs. 54.08±13.77 mg/dL, P<0.01), higher triglyc-
eride levels (42.89±24.90 vs. 32.67±17.74, P<0.01), and higher low-
density lipoprotein levels (33.71±14.37 vs. 27.56±8.94, P<0.01) as
compared to the newborns in the AGA group. High-density lipo-
protein levels and insulin levels were comparable between both
the groups. Anaemia was highly prevalent amongmothers of both
the groups.
Conclusions: SGA newborns are significantly associated with
higher lipid profile as compared to AGA newborns; hence, they are
at higher risk for developing cardiovascular events much early in
life. SGA newborns should be closelymonitored for cardiovascular
morbidities during childhood, adolescence and early adult life.
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Background: The study was carried out to assess the risk of new
diabetes mellitus in patients on statin therapy.
Methods: Hospital records of 1000 non-diabetic subjects (mean
age 63.2 years) attending Preventive Cardiology Clinic of a tertiary
care centre, who had been receiving statin therapy for at least 5
years and regular follow up (study group) were compared with
records of 400 age, gender, and BMI matched non-diabetic sub-
jects who never received statin therapy and were on follow-up for
at least 5 years (control group).
Results: At 5 years, mean fasting plasma glucose (FPG), mean 2-h
post prandial plasma glucose (PPG) and mean HbA1c levels of
study group were significantly higher as compared to control
group (p<0.001, p¼0.016, and p<0.001 respectively). There was a
higher incidence of IFG, IGT and DM, either separately or in
combination in statin group (13.7%, 5.8% and 11.9%, and 31.4% for
IFG, IGT, DM, and any of these) as compared to controls (9.8%,
3.3%, 7.0%, 20% for IFG, IGT, DM, and any of these) and this dif-
ference was statistically significant for a combination of any of
these (p¼0.044, 0.049, 0.007, and <0.001). Simvastatin was associ-
ated with significantly higher incidence of DM as compared to
other statins (p¼0.018). The incidence of DM with statin therapy
was significantly higher with 20-40 mg/day as compared to low
dose statin or control group (p<0.001). On multivariate analysis,
statin use did not emerge to be significantly associated with
development of diabetes mellitus (p¼0.696). However, high doses
(20-40 mg/day) independently increased the risk (p<0.001).
Conclusions: Statins are associated with increased occurrence of
new onset diabetes mellitus, impaired fasting glucose, and
impaired glucose tolerance, either in combination or individually.
The risk is particularly significant with use of high dose statins,
independent of other risk factors, and seems to be a class effect of
statins, though the association appears strongest for simvastatin.
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